JP2023535071A5 - - Google Patents

Info

Publication number
JP2023535071A5
JP2023535071A5 JP2023504597A JP2023504597A JP2023535071A5 JP 2023535071 A5 JP2023535071 A5 JP 2023535071A5 JP 2023504597 A JP2023504597 A JP 2023504597A JP 2023504597 A JP2023504597 A JP 2023504597A JP 2023535071 A5 JP2023535071 A5 JP 2023535071A5
Authority
JP
Japan
Prior art keywords
sample
living cells
approximately
group
target compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023504597A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023535071A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/043012 external-priority patent/WO2022020742A1/en
Publication of JP2023535071A publication Critical patent/JP2023535071A/ja
Publication of JP2023535071A5 publication Critical patent/JP2023535071A5/ja
Pending legal-status Critical Current

Links

JP2023504597A 2020-07-24 2021-07-23 N-ベンジルスルホンアミドの合成と使用 Pending JP2023535071A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063056211P 2020-07-24 2020-07-24
US63/056,211 2020-07-24
PCT/US2021/043012 WO2022020742A1 (en) 2020-07-24 2021-07-23 Synthesis and use of n-benzyl sulfonamides

Publications (2)

Publication Number Publication Date
JP2023535071A JP2023535071A (ja) 2023-08-15
JP2023535071A5 true JP2023535071A5 (cg-RX-API-DMAC10.html) 2024-07-25

Family

ID=79728378

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023504597A Pending JP2023535071A (ja) 2020-07-24 2021-07-23 N-ベンジルスルホンアミドの合成と使用

Country Status (6)

Country Link
US (1) US20230266302A1 (cg-RX-API-DMAC10.html)
EP (1) EP4185706A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023535071A (cg-RX-API-DMAC10.html)
KR (1) KR20230044440A (cg-RX-API-DMAC10.html)
CA (1) CA3186840A1 (cg-RX-API-DMAC10.html)
WO (1) WO2022020742A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114478355B (zh) * 2022-02-24 2023-10-03 安徽大学 一种吲哚啉衍生物的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395506B1 (en) * 1991-04-18 2002-05-28 Becton, Dickinson And Company Device for monitoring cells
US6558916B2 (en) * 1996-08-02 2003-05-06 Axiom Biotechnologies, Inc. Cell flow apparatus and method for real-time measurements of patient cellular responses
US20080050762A1 (en) * 2001-02-13 2008-02-28 Corey Michael J Methods and compositions for coupled luminescent assays
US7083911B2 (en) * 2001-02-16 2006-08-01 Promega Corporation Method for detection of ATP
US6982152B2 (en) * 2002-04-17 2006-01-03 Promega Corporation Cytotoxicity assay
WO2004059294A2 (en) * 2002-12-23 2004-07-15 Promega Corporation Improved luciferase-based assays
US7615361B2 (en) * 2006-03-06 2009-11-10 Ceetox, Inc. Toxicity screening methods
US8183007B2 (en) * 2008-07-22 2012-05-22 Promega Corporation ADP detection based methods using adenylate cyclase and bioluminescence

Similar Documents

Publication Publication Date Title
FI78470C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara dihydropyridinderivat.
DE60225341T2 (de) Neue 1,2,4-triazolverbindung
JP2023126957A (ja) 癌を処置するための併用療法
SI8511419A8 (sl) Postopek za pridobivanje 1,4-dihidropiridina
JP2002523450A5 (cg-RX-API-DMAC10.html)
EA022783B1 (ru) ПРИМЕНЕНИЕ АНАЛОГОВ РОЗУВАСТАТИНА ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНЕННЫХ СОСТОЯНИЙ, КОТОРЫЕ ПОДДАЮТСЯ ЛЕЧЕНИЮ ПУТЕМ ИНГИБИРОВАНИЯ HMG-CoA РЕДУКТАЗЫ
WO2014017515A1 (ja) 4-[5-(ピリジン-4-イル)-1h-1,2,4-トリアゾール-3-イル]ピリジン-2-カルボニトリルの結晶多形およびその製造方法
WO2010129954A1 (en) Treatment of ischemia-reperfusion injury
RS59371B1 (sr) Derivat azol benzena
US20180177782A9 (en) Novel uses
JP2018515439A (ja) 軸方向キラル異性体及びその製造方法と製薬用途
JP2012500258A5 (cg-RX-API-DMAC10.html)
PE20050713A1 (es) Derivados de nicotinamida como inhibidores de pde4
DK167395B1 (da) 2-phenyl-hexahydro-1,2,4-triazin-3,5-dioner, fremgangsmaade til deres fremstilling og dyrelaegemiddel deraf
JP4206381B2 (ja) パーオキシナイトライト測定用試薬
US20100261765A1 (en) Mineralocorticoid receptor modulators
JPS61182558A (ja) 色原体物質又はその混合物と過酸化物を含む安定化学組成物、並びに安定化学組成物を得る方法とそのための安定化化学組成物
JP2020516645A (ja) ジアミノピメリン酸経路を介するリジン生合成の複素環式阻害剤
NO20063865L (no) Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter
SU1340585A3 (ru) Способ получени производных тетразола
PT2405910E (pt) Derivados de rosuvastatina e atorvastatina
JP2023535071A (ja) N-ベンジルスルホンアミドの合成と使用
CN113038949B (zh) 嗜中性白血球发炎抑制剂及其用途
TW200914008A (en) Raf inhibitors for the treatment of thyroid cancer
KR940000460A (ko) 퀴놀린계 유도체와 그의 제조방법